Sesen Bio Inc.

NASDAQ:SESN  
2.67
+0.05 (+1.91%)
Products, Strategic Combinations

Sesen Bio Announces Commercial Manufacturing And Global Supply Partnership With Qilu

Published: 12/07/2020 13:19 GMT
Sesen Bio Inc. (SESN) - Sesen Bio Announces Commercial Manufacturing and Global Supply Partnership With Qilu Pharmaceutical.
Sesen Bio Inc - Technology Transfer to Qilu Anticipated to Be Completed in Mid-2021.
Sesen Bio Inc - to Receive $2 Million Milestone Payment Upon Completion of Technology Transfer.
Sesen Bio Inc - Qilu Will Be Part of Contract Manufacturing Network for Global Commercial Supply of Vicineum in Agreement.
Sesen Bio Inc - on Track to Complete Bla for Vicineum and Submit to FDA Later This Month.